CIDRAP newsletters options
Automated software that simulates people is the primary driver of COVID-19 misinformation, a study finds.
New CDC data show that COVID-19 vaccines have been particularly beneficial for older Americans.
New data show no adverse outcomes in infants exposed to the flu vaccine in utero.
A survey of 164 New York physicians found that one in five were severely distressed during their first COVID-19 triage decisions and last-minute training did not appear to alleviate stress, according to a study yesterday in Disaster Medicine and Public Health Preparedness.
CARB-X announced today that is awarding Tucson, Arizona–based Accelerate Diagnostics $578,000 to develop a diagnostic test for sepsis based on new fiber optic technology.
The slowdown is nationwide, but states in the South and Midwest report plummeting numbers.
Two studies look at pediatric COVID-19 hospitalizations in the United States and Brazil.
Dutch travelers to Asia, Africa acquired 56 unique antimicrobial-resistance genes.
Some Asian countries, like Taiwan, continue to battle stubborn COVID spikes.
The use of rapid respiratory pathogen (RRP) testing among children with influenza-like illness (ILI) did not reduce antibiotic prescribing, according to a randomized clinical trial published late last week in JAMA Network Open.
In a population study of 13- to 18-year-old Icelandic teens, mental health worsened during the COVID-19 pandemic, according to a study late last week in The Lancet Psychiatry.
Most states will not have 70% of adults vaccinated against COVID-19 by Jul 4, an analysis finds.
Pressure grows on wealthy countries that have excess doses to start donating them.
One study suggests that symptoms like fatigue and depression are common, even with mild illness.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Nearly 80% of US patients hospitalized for COVID-19 received antibiotics from March through October 2020, researchers from the Centers for Disease Control and Prevention (CDC) reported yesterday in Open Forum Infectious Diseases.
Preventive use of bamlanivimab lowered the risk of symptomatic COVID-19 in staff and residents of skilled nursing and assisted living facilities in the United States, according to a study yesterday in JAMA.
Also, the White House says it will share 25 million vaccine doses with countries in need of supply.
Only 13% had bacterial infections, but 85% received one or more antibiotics.
Tests showed COVID-19 antibodies persisted for 6 months in most dental workers.
